Hui Gan
Army Medical University(CN)The University of Melbourne(AU)Dalian Medical University(CN)La Trobe University(AU)Austin Hospital(AU)Huzhou University(CN)Wuhan University(CN)Second Affiliated Hospital of Chongqing Medical University(CN)Latrobe Regional Hospital(AU)Donald & Barbara Zucker School of Medicine at Hofstra/Northwell(US)Wuzhou University(CN)Aba Teachers University(CN)Zhongnan Hospital of Wuhan University(CN)Prince Charles Hospital(AU)Beijing Radiation Center(CN)Cancer Research UK Clinical Trials Unit(GB)Wuhan Children's Hospital(CN)Olivia Newton-John Cancer Wellness & Research Centre(AU)Children's Hospital of Chongqing Medical University(CN)Vital Therapies (United States)(US)Austin Health(AU)Austin Health(AU)Chongqing Medical University(CN)Northwest A&F University(CN)
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers, HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research, Radiopharmaceutical Chemistry and Applications
Most-Cited Works
- → Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study(2019)3,087 cited
- → Risk factors for severe and critically ill COVID‐19 patients: A review(2020)1,439 cited
- → The EGFRvIII variant in glioblastoma multiforme(2009)394 cited
- → Antibody–Drug Conjugates for Cancer Therapy(2020)363 cited
- → The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered(2013)353 cited
- → A systematic review of adverse events in randomized trials assessing immune checkpoint inhibitors(2019)242 cited